Immunological status as basis for appropriate treatment in subgroups of HBsAg-positive chronic hepatitis.

about

Interplay of cell and serum immunologic markers in chronic persistent or active hepatitis B.

P2860

Q44954573-C56E3E96-58A8-421A-AC0F-A88056BC28B2

P2860

Immunological status as basis for appropriate treatment in subgroups of HBsAg-positive chronic hepatitis.

Item

http://www.wikidata.org/entity/Q40293650

description

1980 nî lūn-bûn

@nan

1980年の論文

@ja

1980年論文

@yue

1980年論文

@zh-hant

1980年論文

@zh-hk

1980年論文

@zh-mo

1980年論文

@zh-tw

1980年论文

@wuu

1980年论文

@zh

1980年论文

@zh-cn

name

Immunological status as basis ...... Ag-positive chronic hepatitis.

@en

type

Item

label

Immunological status as basis ...... Ag-positive chronic hepatitis.

@en

prefLabel

Immunological status as basis ...... Ag-positive chronic hepatitis.

@en

P1476

Immunological status as basis ...... Ag-positive chronic hepatitis.

@en

P2093

Arnold W

http://www.w3.org/2001/XMLSchema#string

Hess G

http://www.w3.org/2001/XMLSchema#string

Hütteroth I

http://www.w3.org/2001/XMLSchema#string

P2860

Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.

Lymphocyte cytotoxicity in chronic active hepatitis: effect of therapy and correlations with clinical and histological changes.

Cell-mediated immunity in acute and chronic hepatitis.

Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis.

In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis

[Immune mechanisms in uremia].

Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Behaviour of e antigen and antibody during chronic active liver disease. Relation to HB antigen-antibody system and prognosis.

T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.

Localisation of e-antigen in nuclei of hepatocytes in HBsAg-positive liver diseases.

P304

385-388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00365528009181488

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karl-Hermann Meyer zum Büschenfelde

P577

1980-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7001612

http://www.w3.org/2001/XMLSchema#string

P921

immunology

Immunological status as basis for appropriate treatment in subgroups of HBsAg-positive chronic hepatitis.

about

P2860

P2860

Immunological status as basis for appropriate treatment in subgroups of HBsAg-positive chronic hepatitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921